![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 14, 2024 12:59:24 PM
Why?
Why do I think Phase 2 is always required? Oh, I don't know, probably because the MHRA describes the the accelerated review as a 150 day process, not an 80 day process that may be extended to 150 days.
The MHRA offers a 150-day assessment timeline for all high-quality marketing authorisation applications (MAAs),
The assessment process will run in two phases totalling 150 days
National Procedure (a 150-day procedure) only for high-quality applications to market a medicine in the United Kingdom, Great Britain or Northern Ireland
Notice how it is never referred to as a potentially 80 day process?
Your entire argument that Phase 2 can be skipped is based on your clear misinterpretation of the phrase "if required" in the following excerpt, which is being used to reference the necessity of an RFI/clock off period, not the necessity of Phase 2.
The assessment process will run in two phases totalling 150 days with an intervening clock-off period between phase I and phase II, if required.
"between Phase 1 and Phase II" is an adjectival prepositional phrase that only speaks to the subject complement "(intervening clock off) period" and can be removed from the sentence and maintain context. It describes when the subject complement of the sentence occurs (between phase 1 and 2). It is not itself the subject or subject complement. The statement 'if required' refers to the subject complement. The correct way to interpret this statement is by removing the prepositional phrase "between Phase 1 and Phase 2" and reading it thusly: "The assessment process (subject) will run in two phases (subject complement) totalling 150 days with an intervening clock off period (subject complement), if required".
Your argument for skipping Phase 2 is entirely predicated on your misinterpretation of the English language. There is absolutely no evidence that Phase 2, which is when safety, efficacy, and quality of the medicine is evaluated, is ever just skipped.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM